CTMXCytomX Therapeutics, Inc.

$2.46-26% 1Y
Latest close: a new 52-week lowOct 8, 2026what changed →

What is the market doing?

Watch

In a downtrend (−39% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data
TrendDowntrendderived · Oct 8, 2026

In a downtrend, below its 50- and 200-day averages. Price is −39% vs its 200-day average.

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How CTMX is trading

CytomX Therapeutics, Inc. is −26% over the past year while the S&P 500 is +18%: 44 points behind the market.

−26%

1-year return · S&P 500 +18%

vs 200-day average
−39%

vs 200-day average · a clear downtrend

RSI (14)
32

RSI (14) · neutral

Below its 52-week high
64%

Below its 52-week high

Oct 4, 2024$0.43 – $6.75 · dashed line: 200-day averageOct 8, 2026
Details›
Last close2026-10-08
$2.46
1 monthS&P 500 +1.6%
−30%
1 yearS&P 500 +18%
−26%
5 yearsS&P 500 +86%
−52%
vs 50-day average$3.15
−22%
52-week high
$6.75
52-week low
$2.46
Annualised volatility
128%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
−$5K
Calendar-year price return
YearReturn
2026 (year to date)−42%
2025+314%
2024−34%
2023−3.1%
2022−63%
2021−34%
2020−21%
2019−45%
2018−28%
2017+92%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan107 of 10+13%
Feb104 of 10−1.4%
Mar102 of 10−4.7%
Apr104 of 10−1.9%
May104 of 10+20%
Jun105 of 10−2.7%
Jul113 of 11−6.0%
Aug115 of 11−0.77%
Sep113 of 11+1.5%
Oct113 of 11−7.2%
Nov108 of 10+11%
Dec104 of 10−0.44%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.